Evidence map›Paper›PMID 31980556›Full record

ArticleLife science alliance2020

Altering microtubule dynamics is synergistically toxic with spindle assembly checkpoint inhibition.

Klaske M Schukken, Yu-Chih Lin, Petra L Bakker, Michael Schubert, Stephanie F Preuss, Judith E Simon, Hilda van den Bos, Zuzana Storchova, Maria Colomé-Tatché, Holger Bastians and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. The two sides of chromosomal instability: drivers and brakes in cancer.Signal transduction and targeted therapy · 2024
    Review
  3. Role of chromosomal cohesion and separation in aneuploidy and tumorigenesis.Cellular and molecular life sciences : CMLS · 2024
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Klaske M SchukkenEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Yu-Chih LinGoettingen Center for Molecular Biosciences and University Medical Center, Goettingen, Germany.
Petra L BakkerEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Michael SchubertEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-6862-5221
Stephanie F PreussEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0002-6405-5057
Judith E SimonEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Hilda van den BosEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-9787-8597
Zuzana StorchovaDepartment of Molecular Genetics, University of Kaiserslautern, Germany.ORCID https://orcid.org/0000-0003-2376-7047
Maria Colomé-TatchéEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
Holger BastiansGoettingen Center for Molecular Biosciences and University Medical Center, Goettingen, Germany.ORCID https://orcid.org/0000-0001-7915-3648
Diana Cj SpieringsEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.ORCID https://orcid.org/0000-0001-8403-474X
Floris FoijerEuropean Research Institute for the Biology of Ageing, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands f.foijer@umcg.nl.ORCID https://orcid.org/0000-0003-0989-3127
University of Groningen · NLUniversity of Göttingen · DEUniversity of Kaiserslautern · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chromosomal instability (CIN) and aneuploidy are hallmarks of cancer. As most cancers are aneuploid, targeting aneuploidy or CIN may be an effective way to target a broad spectrum of cancers. Here, we perform two small molecule compound screens to identify drugs that selectively target cells that are aneuploid or exhibit a CIN phenotype. We find that aneuploid cells are much more sensitive to the energy metabolism regulating drug ZLN005 than their euploid counterparts. Furthermore, cells with an ongoing CIN phenotype, induced by spindle assembly checkpoint (SAC) alleviation, are significantly more sensitive to the Src kinase inhibitor SKI606. We show that inhibiting Src kinase increases microtubule polymerization rates and, more generally, that deregulating microtubule polymerization rates is particularly toxic to cells with a defective SAC. Our findings, therefore, suggest that tumors with a dysfunctional SAC are particularly sensitive to microtubule poisons and, vice versa, that compounds alleviating the SAC provide a powerful means to treat tumors with deregulated microtubule dynamics.

Indexed as

AneuploidyAniline CompoundsBenzimidazolesChromosomal InstabilityDrug SynergismGene Knockdown TechniquesHT29 CellsHumansKineticsMCF-7 CellsMicrotubulesM Phase Cell Cycle CheckpointsNeoplasmsNitrilesPhenotypePolymerizationAniline CompoundsBenzimidazolesbosutinibNitrilesProtein Kinase InhibitorsQuinolinessrc-Family KinasesZLN005

Identifiers

PMID31980556
PMCPMC6985455
OpenAlexW3001420422

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.